Bristol Immunisation Group HIT News
Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2?
Emerging evidence indicates that many currently defined aerosol generating procedures (AGPs) are unlikely to play…
Bristol City Council's webinar tackles the myths and misinformation around the COVID-19 vaccine
On Tuesday, 26 January, 2021, the Bristol City Council Race Equality COVID-19 Steering Group held…
Children needed for STORY study on how immune systems respond to COVID-19
A study looking at how children’s immune systems respond to COVID-19, and to vaccines for…
HIT Conference goes virtual to address the impact of COVID-19 and wider health inequalities
Bristol Health Partners held its annual Health Integration Team (HIT) Conference as an entirely…
Discovery of a druggable pocket in the SARS-CoV-2 Spike protein could stop virus in its tracks
A druggable pocket in the SARS-CoV-2 Spike protein that could be used to stop the…
Bristol Immunisation Group HIT's achievements in 2019-20
Bristol Immunisation Group (BIG) HIT Directors Professor Adam Finn, Dr Julie Yates…
BIG HIT Director coordinates University of Bristol efforts to fight COVID-19
Experts at the University of Bristol have come together to help in the fight against…
Bristol Immunisation Group review of 2018-19
Professor Adam Finn, Dr Julie Yates and Dr Marion Roderick, Directors of the Bristol Immunisation…
HITs secure £2.9 million in research funding in 2018-19
Bristol Health Partners Health Integration Teams (HITs) have attracted nearly £2.9 million in research funding…
Health Integration Teams secure nearly £1.5 million in the first quarter of 2018/19
Bristol Health Integration Teams (HITs) have secured £1,438,000 of funding in the first quarter of…
Bristol Immunisation Group looks back at 2017-18
Professor Adam Finn, Dr Julie Yates and Dr Marion Roderick, Directors of the Bristol Immunisation…
